Translational Geroscience

Felipe Sierra. Expert Consultation.

Translational Geroscience for Experimental Treatments.
Work directly with Felipe Sierra to strengthen the translational strategy behind your experimental treatment.

Together, you'll evaluate scientific priorities and prepare your therapy for emerging clinical access pathways.
Designed for biotechs preparing experimental treatment submissions.
Preparing for Your Consultation.
To make the most of your session, share any available background information in advance, including a brief description of the therapy, supporting evidence, development stage, and any specific scientific questions they would like to discuss.
Selected Credentials
200+
Scientific Publications.
20+
Years of Research.
3
Scientific Fellowships.
01 OVERVIEW

Why Book This Consultation.

Experimental treatment submissions require scientific decisions that often extend beyond published guidance.

Evaluating evidence quality, identifying potential risks, and strengthening submission strategy all benefit from expert review before important decisions are made.
This consultation gives treatment developers direct access to Matt Kaeberlein's scientific insight to evaluate their therapy, strengthen submission strategy, and move forward with greater confidence.

How the Consultation Works.

Hear directly from Matt Kaeberlein about the scientific approach behind this consultation and how it can strengthen your treatment development strategy.
·

Strengthen Your Submission.

Receive expert feedback to improve the scientific foundation of your therapy before independent review.
·

Reduce Scientific Risk.

Identify potential weaknesses, evidence gaps, and strategic questions before they become costly delays.
·

Accelerate Decision Making.

Receive expert feedback to improve the scientific foundation of your therapy before independent review.
Designed for biotechs preparing
experimental treatment submissions.
02 Details

Consultation Scope.

Every consultation with Matt Kaeberlein is tailored to the current stage, challenges, and objectives of your treatment.
The discussion may include one or more of the focus areas below, depending on your treatment's priorities.

Scientific Rationale.

Evaluate whether the scientific foundation of your therapy is ready for submission.

Evidence Review.

Assess supporting data, identify evidence gaps, and discuss opportunities to strengthen your submission..

Submission Strategy.

Receive expert feedback to improve the scientific foundation of your therapy before independent review.

Development Planning.

Review next steps based on your therapy's current stage and long-term objectives.

Clinical Translation.

Explore practical considerations for moving promising therapies toward patient access.

Open Scientific Discussion

Bring specific questions about your therapy, development program, or submission strategy.

Consultation Details:

Duration:
30 or 60 min
Format:
Remote (Google Meet)
Availability:
Mon-Fri, 09:00-12:00
Time Zone:
Pacific Time (UTC−8)

Best Suited For:

Biotechnology companies

Clinical-stage therapeutic developers

Research organizations

Sponsors preparing experimental treatment submissions

Teams evaluating scientific evidence and development strategy

Expected Outcomes:

Clear next steps for your treatment strategy

Practical scientific recommendations

Greater confidence in your submission approach

Answers to your most important technical questions
EXPERT PROFILE

Scientific Leadership.

Felipe Sierra, PhD, is a biochemist and translational geroscientist whose work has helped define the modern field of geroscience.

During his leadership at the National Institute on Aging, he championed research connecting the biology of aging with the prevention and treatment of age-related disease.
Through this consultation, Felipe works directly with biotechnology teams to evaluate translational research strategies, strengthen scientific priorities, and discuss approaches for advancing therapies from discovery toward clinical application.

Professional Highlights.

Former Director:
Division of Aging Biology
National Institute on Aging (NIH)
Scientific Leadership:
Founder, NIH Geroscience Interest Group

Chair, Trans-NIH Geroscience Interest Group
Research Leadership:
Development of the Geroscience framework

Translational aging research
International Speaker:
Global advisor on aging biology and translational geroscience

Affiliations.

Expert guidance for critical scientific
and submission decisions.
03 Process

Consultation Process.

Every consultation follows a straightforward process designed to maximize the value of your time with Matt Kaeberlein.
From booking to preparation and the consultation itself and follow ups, each step is focused on providing practical scientific guidance tailored to your therapy.

01

Schedule Your Consultation.

Select the consultation length that best fits your needs and choose an available time directly from Matt Kaeberlein's calendar.

02

Share Your Background.

Before the meeting, provide any relevant materials, including information about your therapy, supporting evidence, development stage, and the scientific questions you'd like to discuss.

This allows the consultation to focus immediately on the topics most relevant to your team.

03

Iterate with
Matt Kaeberlein.

Discuss your therapy directly with Matt, receive scientific feedback tailored to your treatment, explore strategic questions, and leave with practical recommendations for your next stage of development.
03 Process

Consultation Process.

Every consultation follows a straightforward process designed to maximize the value of your time with Matt Kaeberlein.
From booking to preparation and the consultation itself and follow ups, each step is focused on providing practical scientific guidance tailored to your therapy.

01

Schedule Your Consultation.

Select the consultation length that best fits your needs and choose an available time directly from Matt Kaeberlein's calendar.

02

Share Your Background.

Before the meeting, provide any relevant materials, including information about your therapy, supporting evidence, development stage, and the scientific questions you'd like to discuss.

03

Iterate with Matt Kaeberlein.

Discuss your therapy directly with Matt, receive scientific feedback tailored to your treatment, explore strategic questions, and leave with practical recommendations for your next stage of development.